CD8A and neoplasm: As main effector cells for tumor immune surveillance and clearance, CD8+ T cells recognize tumor antigens presented by antigen-presenting cells (APCs) such as dendritic cells (DCs) through the major histocompatibility complex class I (MHC-I), leading to the killing of cancer cells [10].